2013 American Transplant Congress

May 18-22, 2013 in Seattle, Washington

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Transplant Glomerulopathy – An Analysis of 96 Cases To Determine the Risk Factors of Allograft Failure

P. Patri, T. Muthukumar, S. Iwasaki, J. Lee, D. Dadhania, C. Hartono, M. Suthanthiran, S. Seshan
Transplant Renal Arterial Inflow Stenosis Defined by Contrast Enhanced MR Angiography and MR Imaging in Early Period after Renal Transplantation: Predisposing Factors and Clinical Outcomes

J. Hwang, S. Park, B. Choi, H. Chun, J. Kim, C. Yang, Y. Kim, I. Moon
Transplantation of CDC High Risk Kidneys: A Low Risk Option for a High Risk Problem

J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Palanisamy, U. Farooq, Y. Al-Shraideh, W. Doares, S. Kaczmorski, M. Gautreaux, S. Winfrey, V. Uloko, S. Iskandar, E. Brim, G. Hairston, R. Stratta
Transplantation Outcomes in Treating Primary Hyperoxaluria (PH) in Pittsburgh. Is the Liver Really That Important?

H. Lam, V. Gunabushanam, E. Bakosi, P. Sood, A. Humar, M. Sturdevant
Transplantation Tolerance That Depends on Regulatory T Cells Induced by TGF-beta-Producing Regulatory B Cells

J. Kim, K. Lee, G. Zhao, R. Stott, J. Soohoo, M. Lian, L. Fitzgerald, H. Yeh, S. Deng, J. Markmann
Transplantation Tourism: High Risk for the Recipients

A. El-Agroudy, S. Ghareeb, S. Alarrayed, E. Farid, H. Alhellow, S. Abdulla
Treatment of Chronic Antibody-Mediated Rejection after Kidney Transplantation: Does Rituximab and Intravenous Globulins Improve Graft Survival?

L. Ghouti-Terki, B. Sautenet, C. Barbet, J. Halimi, Y. Lebranchu, C. Magdelaine, C. Baron, M. Büchler, P. Gatault
Treatment of Cryptococcosis in Solid-OrganTransplant Recipients: Relapse Is Rare after Discontinuation of Therapy

J. Baddley, B. Klausing, K. Brizendine, V. Kumar, B. Julian, D. Eckhoff, J. Tallaj, K. Wille, S. Moser, P. Pappas
Treatment of Late Onset De Novo Donor Specific Antibody (DSA)-Mediated Pediatric Kidney Transplant Rejection with Bortezomib

J. Ghata, P. Sindhwani, T. Lewis, M. Turman
Treatment of Renal Transplant Patients with Autologous Bone Marrow Derived Mesenchymal Stromal Cells Downregulates the Donor Specific Mixed Lymphocyte Reaction

M. Reinders, J. de Fijter, H. Roelofs, D. de Vries, F. Claas, P. van Miert, D. Roelen, C. van Kooten, T. Rabelink

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z